<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Assessment of <z:chebi fb="0" ids="16978">Leukotriene C4</z:chebi> (<z:chebi fb="0" ids="16978">LTC4</z:chebi>) activity in the serum and cerebrospinal fluid (CSF) specimens of patients with multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> (MS), <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e>, <z:hpo ids='HP_0007354'>amyotrophic lateral sclerosis</z:hpo> (ALS), <z:hpo ids='HP_0003473'>Myasthenia</z:hpo> gravis (MG), <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet, as well as in <z:mpath ids='MPATH_458'>normal</z:mpath> controls were carried out in order to determine its role in the pathogenesis of <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurologic disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="16978">LTC4</z:chebi> levels were found to be elevated in MS and <z:chebi fb="6" ids="22696">Beh</z:chebi>çet patient in comparison with controls </plain></SENT>
<SENT sid="2" pm="."><plain>Augmentation of <z:chebi fb="0" ids="16978">LTC4</z:chebi> levels underlines the fact that <z:chebi fb="0" ids="25029">leukotrienes</z:chebi> may be held responsible the pathogenesis of these disorders </plain></SENT>
</text></document>